Pharmacokinetics and aqueous humor penetration of levofloxacin 1.5% and moxifloxacin 0.5% in patients undergoing cataract surgery

Frank A Bucci Jr, Ines Teuma Nguimfack, Angel T Fluet Bucci Laser Vision Institute, Wilkes-Barre, PA, USA Purpose: The objective of this study was to compare the pharmacokinetics of levofloxacin 1.5% and moxifloxacin hydrochloride 0.5% ophthalmic solutions in aqueous humor after multiple doses pri...

Full description

Bibliographic Details
Main Authors: Bucci Jr FA, Nguimfack IT, Fluet AT
Format: Article
Language:English
Published: Dove Medical Press 2016-05-01
Series:Clinical Ophthalmology
Subjects:
Online Access:https://www.dovepress.com/pharmacokinetics-and-aqueous-humor-penetration-of-levofloxacin-15-and--peer-reviewed-article-OPTH
id doaj-73d7f1c4882c4271bc891a4305413574
record_format Article
spelling doaj-73d7f1c4882c4271bc891a43054135742020-11-25T01:19:09ZengDove Medical PressClinical Ophthalmology1177-54832016-05-012016Issue 178378926712Pharmacokinetics and aqueous humor penetration of levofloxacin 1.5% and moxifloxacin 0.5% in patients undergoing cataract surgeryBucci Jr FANguimfack ITFluet ATFrank A Bucci Jr, Ines Teuma Nguimfack, Angel T Fluet Bucci Laser Vision Institute, Wilkes-Barre, PA, USA Purpose: The objective of this study was to compare the pharmacokinetics of levofloxacin 1.5% and moxifloxacin hydrochloride 0.5% ophthalmic solutions in aqueous humor after multiple doses prior to cataract surgery. Methods: Ninety-eight eyes underwent cataract surgery and met the requirements of PK analysis. Eligible eyes were randomly assigned in a 1:1 ratio to receive levofloxacin or moxifloxacin prior to cataract surgery and were randomized into one of four sampling time points (ie, 1, 2, 4, and 6 hour post-last dose). Randomization was investigator and laboratory-masked. Three days prior to cataract surgery, each patient instilled one drop of the assigned study medication into the operative eye four times daily. One aqueous humor specimen was collected from the eye at the randomized time point. Aqueous humor specimens were assayed for drug concentration using a validated liquid chromatography and tandem mass spectrometer. Results: Concentrations of the drug in the aqueous humor, as described by mean Cmax and pooled AUC0–6 values, were greater for levofloxacin than moxifloxacin (Cmax: 1.43, 0.87 µg/ml, respectively, P=0.008; AUC0–6 6.1, 3.8 µg·min/ml, P<0.001 respectively). No treatment-emergent adverse events were reported. Conclusion: Significantly greater drug exposures were attained in aqueous humor following the administration of levofloxacin 1.5% than moxifloxacin 0.5% ophthalmic solution. Achieving considerable higher drug concentration in the aqueous humor with levofloxacin 1.5% may demonstrate a greater potential for bacterial eradication. Keywords: concentration, endophthalmitis, antibiotics, phacoemulsification, prophylaxis, fluoroquinolonehttps://www.dovepress.com/pharmacokinetics-and-aqueous-humor-penetration-of-levofloxacin-15-and--peer-reviewed-article-OPTHmoxifloxacin 0.5% levofloxacin 1.5% keratitisendophthalmitisaqueous humor absorptioncataract surgeryphacoemulsification
collection DOAJ
language English
format Article
sources DOAJ
author Bucci Jr FA
Nguimfack IT
Fluet AT
spellingShingle Bucci Jr FA
Nguimfack IT
Fluet AT
Pharmacokinetics and aqueous humor penetration of levofloxacin 1.5% and moxifloxacin 0.5% in patients undergoing cataract surgery
Clinical Ophthalmology
moxifloxacin 0.5% levofloxacin 1.5% keratitis
endophthalmitis
aqueous humor absorption
cataract surgery
phacoemulsification
author_facet Bucci Jr FA
Nguimfack IT
Fluet AT
author_sort Bucci Jr FA
title Pharmacokinetics and aqueous humor penetration of levofloxacin 1.5% and moxifloxacin 0.5% in patients undergoing cataract surgery
title_short Pharmacokinetics and aqueous humor penetration of levofloxacin 1.5% and moxifloxacin 0.5% in patients undergoing cataract surgery
title_full Pharmacokinetics and aqueous humor penetration of levofloxacin 1.5% and moxifloxacin 0.5% in patients undergoing cataract surgery
title_fullStr Pharmacokinetics and aqueous humor penetration of levofloxacin 1.5% and moxifloxacin 0.5% in patients undergoing cataract surgery
title_full_unstemmed Pharmacokinetics and aqueous humor penetration of levofloxacin 1.5% and moxifloxacin 0.5% in patients undergoing cataract surgery
title_sort pharmacokinetics and aqueous humor penetration of levofloxacin 1.5% and moxifloxacin 0.5% in patients undergoing cataract surgery
publisher Dove Medical Press
series Clinical Ophthalmology
issn 1177-5483
publishDate 2016-05-01
description Frank A Bucci Jr, Ines Teuma Nguimfack, Angel T Fluet Bucci Laser Vision Institute, Wilkes-Barre, PA, USA Purpose: The objective of this study was to compare the pharmacokinetics of levofloxacin 1.5% and moxifloxacin hydrochloride 0.5% ophthalmic solutions in aqueous humor after multiple doses prior to cataract surgery. Methods: Ninety-eight eyes underwent cataract surgery and met the requirements of PK analysis. Eligible eyes were randomly assigned in a 1:1 ratio to receive levofloxacin or moxifloxacin prior to cataract surgery and were randomized into one of four sampling time points (ie, 1, 2, 4, and 6 hour post-last dose). Randomization was investigator and laboratory-masked. Three days prior to cataract surgery, each patient instilled one drop of the assigned study medication into the operative eye four times daily. One aqueous humor specimen was collected from the eye at the randomized time point. Aqueous humor specimens were assayed for drug concentration using a validated liquid chromatography and tandem mass spectrometer. Results: Concentrations of the drug in the aqueous humor, as described by mean Cmax and pooled AUC0–6 values, were greater for levofloxacin than moxifloxacin (Cmax: 1.43, 0.87 µg/ml, respectively, P=0.008; AUC0–6 6.1, 3.8 µg·min/ml, P<0.001 respectively). No treatment-emergent adverse events were reported. Conclusion: Significantly greater drug exposures were attained in aqueous humor following the administration of levofloxacin 1.5% than moxifloxacin 0.5% ophthalmic solution. Achieving considerable higher drug concentration in the aqueous humor with levofloxacin 1.5% may demonstrate a greater potential for bacterial eradication. Keywords: concentration, endophthalmitis, antibiotics, phacoemulsification, prophylaxis, fluoroquinolone
topic moxifloxacin 0.5% levofloxacin 1.5% keratitis
endophthalmitis
aqueous humor absorption
cataract surgery
phacoemulsification
url https://www.dovepress.com/pharmacokinetics-and-aqueous-humor-penetration-of-levofloxacin-15-and--peer-reviewed-article-OPTH
work_keys_str_mv AT buccijrfa pharmacokineticsandaqueoushumorpenetrationoflevofloxacin15andmoxifloxacin05inpatientsundergoingcataractsurgery
AT nguimfackit pharmacokineticsandaqueoushumorpenetrationoflevofloxacin15andmoxifloxacin05inpatientsundergoingcataractsurgery
AT fluetat pharmacokineticsandaqueoushumorpenetrationoflevofloxacin15andmoxifloxacin05inpatientsundergoingcataractsurgery
_version_ 1725139714260860928